DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment




MRI Homepage

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Bruker and the Champalimaud Foundation to develop first 18 Tesla UHF MR scanner Enable discovery of new contrast mechanisms

Helium shortage could have deflating effect on MR industry Party City cites shortage as contributor to 45 stores closing

MR method could spare patients with skull lesions from CT, says study Could benefit children and pregnant women

Synaptive unveils dedicated head MR system, Evry Will help in assessing the role of MR in emergency departments

AI comparable to radiologists in prostate cancer detection accuracy Identifies and predicts aggressiveness using MR scans

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

Sound Imaging launches MR patient motion and detection system, SAMM MD Reduces repeat scans, prevents interruption to workflow

Whole Body MR may reduce the
time needed to diagnose stages
of cancer

Whole body MR may support faster, less expensive cancer treatment planning

por John R. Fischer , Staff Reporter
A group of researchers in the U.K. have found that whole body MR imaging may reduce the time required for staging and planning cancer treatment, based on two prospective trials.

Conducted on nearly 500 patients across 16 hospitals, the Streamline C and Streamline L trials compared whole body MR to multiple imaging techniques currently recommended by guidelines to assess patients recently diagnosed with colorectal cancer and non-small cell lung cancer, respectively.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

“The current guidelines still recommend multiple techniques because, to date, there has been limited supportive data for WB-MR from large prospective multicenter studies such as the Streamline trials,” lead author Stuart Taylor, professor of medical imaging at University College London, told HCB News. “Until now, studies supporting the use of WB-MR have mainly been quite small, performed at one or two hospital sites only and used a small number of experienced radiologists to interpret the scans. Health care policy makers cannot use this level of evidence to recommend WB-MR. We hope the Streamline trials will change this.”

Determining the right course of treatment for cancer requires clinicians to know the size of a tumor and the extent to which is has spread to nearby lymph nodes, as well as other parts of the body. Standard pathways outlined by the National Health Service involve different imaging modalities, such as CT, PET/CT or focused MR, which vary in accuracy depending on the organ. As such, several appointments and follow-up exams can be required.

WB-MR, which can image the entire body in one hour or less, was found to reduce the average time for determining tumor size, and the extent of spreading, by five days for colorectal cancer patients and six for lung cancer patients.

While sensitivity and specificity of diagnosis for WB-MR did not vary from that of standard tests for both forms of cancer, it did reduce the time required for complete diagnostic exams from an average of 13 to eight days for colorectal cancer patients, and from 19 to 23 days for those with lung cancer. Costs also decreased from an average of £285 to £216 in the colorectal cancer trial and an average of £620 to £317 in the lung cancer trial.

MR technology, however, is lacking in availability compared to other imaging modalities, due to its high demand, according to Taylor. Many hospitals in the trials, for instance, were unable to make time on their MR scanners, forcing patients to receive exams at nearby practices. Additionally, eight of the 16 hospitals in the colorectal trial lacked the infrastructure necessary to perform WB-MR, as did 11 of 16 in the lung cancer trial.
  Pages: 1 - 2 >>

MRI Homepage

You Must Be Logged In To Post A Comment

Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2019, Inc.